Department of Immunotechnology
1 – 10 of 116
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Exploring the Signature Matrix Creation Process for Cell Type Deconvolution Using Proteomics Data
- Master (Two yrs)
-
Mark
Effects of Treatment of High-Grade Serous Ovarian Cancer Tumors at the Single-Cell Level
- Master (Two yrs)
-
Mark
Proteomics and Phosphoproteomics Analysis of Parental and Cisplatin-Resistant Ovarian Cancer Cell Lines Treated with C26A6 and Volasertib
- Master (Two yrs)
-
Mark
Activation of Antigen Presenting Cells Following Stimulation with a CD40-CEACAM5 Bispecific Antibody, in an ex vivo Esophagogastric Adenocarcinoma Model
- Master (Two yrs)
-
Mark
Exploring Tumor Modeling and Immunotoxicology - Precision-Cut Tumor Slices of Head and Neck Squamous Cell Carcinoma and Immune Response to Nanoplastics
- Master (Two yrs)
-
Mark
Proteomics and Phosphoproteomics of High-Grade Serous Ovarian Carcinoma Models Investigating Ferroptosis Induction and MTDH-SND1 Inhibition
- Master (Two yrs)
-
Mark
Investigation of MTDH and SND1 Expression and Inhibition in Ovarian Cancer
- Master (Two yrs)
-
Mark
Proteomic characterisation of immune cells with a novel FACS-into-evotip workflow
- Master (Two yrs)
-
Mark
Precision cut tumor slices as an ex vivo model to assess myeloid biology and function in the tumor microenvironment
- Master (Two yrs)
-
Mark
Size-dependent Mechanisms of Lipid Nanoparticle Induced Endosomal Escape
- Master (Two yrs)